{"timestamp": 1771604712.1522114, "value": {"ticker": "PLYX", "company_name": "Polaryx Therapeutics, Inc.", "short_name": "Polaryx Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 0, "float_shares": 12063150, "shares_outstanding": 0, "short_ratio": 0, "short_percent_of_float": 0, "shares_short": 0, "shares_short_prior": 0, "insider_percent_held": 0.5279, "institution_percent_held": 0.0, "total_cash": 5745000, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 8.773, "book_value": 0.113, "price_to_book": 22.23894, "operating_cashflow": -3314000, "free_cashflow": 0, "price": 2.513, "52w_high": 48.91, "52w_low": 2.2, "avg_volume": 169480, "avg_volume_10d": 169480, "full_time_employees": 11, "audit_risk": 0, "overall_risk": 0}}